Resmed Inc. buy The Goldman Sachs Group, Inc.
Start price
16.01.25
/
50%
€228.00
Target price
16.01.26
-
Performance (%)
-2.81%
End price
17.01.26
€221.60
Summary
This prediction ended on 17.01.26 with a price of €221.60. With a performance of -2.81%, the BUY prediction by The_Goldman_Sachs_Gr finished with a loss. A total of €0.51 was paid as dividends for this prediction. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 10.707% | 10.707% | -22.183% |
| iShares Core DAX® | 1,01 % | 2,70 % | 4,36 % |
| iShares Nasdaq 100 | -6,47 % | -8,77 % | 18,00 % |
| iShares Nikkei 225® | -6,52 % | -12,58 % | 40,91 % |
| iShares S&P 500 | -2,72 % | -1,75 % | 16,97 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten